Caris Life Sciences Inc.

NASDAQ: CAI · Real-Time Price · USD
39.30
1.18 (3.10%)
At close: Aug 22, 2025, 3:59 PM
39.90
1.53%
After-hours: Aug 22, 2025, 07:41 PM EDT

Caris Life Sciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q2 2024 Q1 2024 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Jun 30, 2024 Mar 31, 2024 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
483.04M 301.64M 180.73M 80.68M 331.64M 309.87M 299.9M
Cost of Revenue
248.62M 180.91M 117.06M 54.56M 155.31M 139M 125.02M
Gross Profit
234.42M 120.73M 63.67M 26.11M 176.33M 170.87M 174.88M
Operating Income
-65.18M -83.17M -25.21M -92.22M 202.11M 171.22M 153.39M
Interest Income
6.53M 4.91M 4.41M 1.77M n/a n/a n/a
Pretax Income
-351.58M -279.8M -177.21M -111.03M 182.39M 145.88M 123.14M
Net Income
-351.58M -279.8M -177.21M -111.03M 139.08M 103.37M 64.8M
Selling & General & Admin
362.32M 255.69M 163.74M 83.96M 34.92M 35.7M 39.4M
Research & Development
107.28M 82.23M 59.16M 34.38M n/a n/a n/a
Other Expenses
-170M -134.02M -134.02M n/a n/a n/a n/a
Operating Expenses
299.59M 203.9M 88.88M 118.34M 34.92M 35.7M 39.4M
Interest Expense
54.95M 35.75M 22.96M 9.29M 29.25M 45.88M 52.36M
Selling & Marketing Expenses
158.05M 115.79M 77.2M 38.49M -1.15M 5.54M 12.01M
Cost & Expenses
548.22M 384.81M 205.94M 172.9M 190.24M 174.71M 164.42M
Income Tax Expense
n/a n/a n/a n/a 10.43M 8.1M 7.36M
Shares Outstanding (Basic)
64.92M 254.79M 254.79M 254.79M 17.34M 17.28M 17.27M
Shares Outstanding (Diluted)
64.92M 254.79M 254.79M 254.79M 17.53M 17.48M 17.52M
EPS (Basic)
-9.25 -1.28 -0.88 -0.53 8.02 5.95 3.71
EPS (Diluted)
-9.25 -1.28 -0.88 -0.53 7.92 5.87 3.66
EBITDA
-253.86M -207.69M -124.94M -84.03M 293.62M 269.94M 236.22M
EBIT
-296.63M -244.05M -154.25M -101.74M 156.81M 191.75M 175.5M
Depreciation & Amortization
42.77M 36.36M 29.32M 17.7M 114.85M 112.59M 111.7M